Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Consequences of chronic frequent premature atrial contractions: Association with cardiac arrhythmias and cardiac structural changes.

Gunda S, Akyeampong D, Gomez-Arroyo J, Jovin DG, Kowlgi NG, Kaszala K, Tan AY, Koneru JN, Kron J, Ellenbogen KA, Huizar JF.

J Cardiovasc Electrophysiol. 2019 Jul 16. doi: 10.1111/jce.14067. [Epub ahead of print]

PMID:
31310360
2.

Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases.

Kwapiszewska G, Johansen AKZ, Gomez-Arroyo J, Voelkel NF.

Circ Res. 2019 Jul 19;125(3):356-366. doi: 10.1161/CIRCRESAHA.119.315054. Epub 2019 Jun 26.

PMID:
31242807
3.

Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients.

González-Pacheco H, Bojalil R, Amezcua-Guerra LM, Sandoval J, Eid-Lidt G, Arias-Mendoza A, Azar-Manzur F, Álvarez-Sangabriel A, Altamirano-Castillo A, Briseño-Cruz JL, Carrillo-Vega J, Vazquez-Rangel A, Abbate A, Gomez-Arroyo J, Martínez-Sánchez C.

J Cardiol. 2019 May;73(5):416-424. doi: 10.1016/j.jjcc.2018.11.010. Epub 2018 Dec 29.

PMID:
30600191
4.

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.

Best MG, Sol N, In 't Veld SGJG, Vancura A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard HJ, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T.

Cancer Cell. 2017 Aug 14;32(2):238-252.e9. doi: 10.1016/j.ccell.2017.07.004.

5.

p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD.

Mizuno S, Ishizaki T, Kadowaki M, Akai M, Shiozaki K, Iguchi M, Oikawa T, Nakagawa K, Osanai K, Toga H, Gomez-Arroyo J, Kraskauskas D, Cool CD, Bogaard HJ, Voelkel NF.

Chest. 2017 Jul;152(1):58-69. doi: 10.1016/j.chest.2017.03.012. Epub 2017 Mar 15.

PMID:
28315337
6.

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together.

Gomez-Arroyo J, Voelkel NF, Huizar JF, Abbate A.

JACC Basic Transl Sci. 2017 Feb 27;2(1):36-38. doi: 10.1016/j.jacbts.2016.11.003. eCollection 2017 Feb. No abstract available.

7.

Pulmonary arterial hypertension and the Enigma code of smouldering inflammation.

Gomez-Arroyo J, Abbate A, Voelkel NF.

Eur Respir J. 2016 Aug;48(2):305-7. doi: 10.1183/13993003.00996-2016. No abstract available.

8.
9.

Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments.

Sandoval J, Gomez-Arroyo J, Gaspar J, Pulido-Zamudio T.

J Cardiol. 2015 Oct;66(4):304-14. doi: 10.1016/j.jjcc.2015.02.001. Epub 2015 Mar 11. Review.

10.

Iloprost reverses established fibrosis in experimental right ventricular failure.

Gomez-Arroyo J, Sakagami M, Syed AA, Farkas L, Van Tassell B, Kraskauskas D, Mizuno S, Abbate A, Bogaard HJ, Byron PR, Voelkel NF.

Eur Respir J. 2015 Feb;45(2):449-62. doi: 10.1183/09031936.00188013. Epub 2014 Sep 26.

11.

Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.

Gomez-Arroyo J, Sandoval J, Simon MA, Dominguez-Cano E, Voelkel NF, Bogaard HJ.

Ann Am Thorac Soc. 2014 Sep;11(7):1101-15. doi: 10.1513/AnnalsATS.201312-425FR. Review.

PMID:
25079379
12.

Histone deacetylase inhibition with trichostatin A does not reverse severe angioproliferative pulmonary hypertension in rats (2013 Grover Conference series).

De Raaf MA, Hussaini AA, Gomez-Arroyo J, Kraskaukas D, Farkas D, Happé C, Voelkel NF, Bogaard HJ.

Pulm Circ. 2014 Jun;4(2):237-43. doi: 10.1086/675986.

13.

The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.

Voelkel NF, Gomez-Arroyo J.

Am J Respir Cell Mol Biol. 2014 Oct;51(4):474-84. doi: 10.1165/rcmb.2014-0045TR. Review.

PMID:
24932885
14.

SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.

de Raaf MA, Schalij I, Gomez-Arroyo J, Rol N, Happé C, de Man FS, Vonk-Noordegraaf A, Westerhof N, Voelkel NF, Bogaard HJ.

Eur Respir J. 2014 Jul;44(1):160-8. doi: 10.1183/09031936.00204813. Epub 2014 May 2.

15.

Differences in right ventricular remodeling secondary to pressure overload in patients with pulmonary hypertension.

Gomez-Arroyo J, Santos-Martinez LE, Aranda A, Pulido T, Beltran M, Muñoz-Castellanos L, Dominguez-Cano E, Sonnino C, Voelkel NF, Sandoval J.

Am J Respir Crit Care Med. 2014 Mar 1;189(5):603-6. doi: 10.1164/rccm.201309-1711LE. No abstract available.

PMID:
24579837
16.

Mechanisms of right heart failure-A work in progress and a plea for failure prevention.

Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ.

Pulm Circ. 2013 Jan;3(1):137-43. doi: 10.4103/2045-8932.109957. No abstract available.

17.

Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.

Drake JI, Gomez-Arroyo J, Dumur CI, Kraskauskas D, Natarajan R, Bogaard HJ, Fawcett P, Voelkel NF.

Physiol Genomics. 2013 Jun 17;45(12):449-61. doi: 10.1152/physiolgenomics.00166.2012. Epub 2013 Apr 30.

18.

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.

Nicolls MR, Mizuno S, Taraseviciene-Stewart L, Farkas L, Drake JI, Al Husseini A, Gomez-Arroyo JG, Voelkel NF, Bogaard HJ.

Pulm Circ. 2012 Oct;2(4):434-42. doi: 10.4103/2045-8932.105031.

19.

Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.

Gomez-Arroyo J, Mizuno S, Szczepanek K, Van Tassell B, Natarajan R, dos Remedios CG, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, Chalfant CE, Bigbee J, Abbate A, Lesnefsky EJ, Bogaard HJ, Voelkel NF.

Circ Heart Fail. 2013 Jan;6(1):136-44. doi: 10.1161/CIRCHEARTFAILURE.111.966127. Epub 2012 Nov 14.

20.

Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?

Voelkel NF, Bogaard HJ, Al Husseini A, Farkas L, Gomez-Arroyo J, Natarajan R.

Antioxid Redox Signal. 2013 May 10;18(14):1810-7. doi: 10.1089/ars.2012.4828. Epub 2012 Sep 28. Review.

PMID:
22870869
21.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Mizuno S, Farkas L, Al Husseini A, Farkas D, Gomez-Arroyo J, Kraskauskas D, Nicolls MR, Cool CD, Bogaard HJ, Voelkel NF.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):679-87. doi: 10.1165/rcmb.2012-0077OC. Epub 2012 Jul 27.

22.

Severe pulmonary hypertension: The role of metabolic and endocrine disorders.

Bogaard HJ, Al Husseini A, Farkas L, Farkas D, Gomez-Arroyo J, Abbate A, Voelkel NF.

Pulm Circ. 2012 Apr-Jun;2(2):148-54. doi: 10.4103/2045-8932.97592.

23.

Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.

Al Husseini A, Bagnato G, Farkas L, Gomez-Arroyo J, Farkas D, Mizuno S, Kraskauskas D, Abbate A, Van Tassel B, Voelkel NF, Bogaard HJ.

Eur Respir J. 2013 Jan;41(1):104-14. doi: 10.1183/09031936.00196511. Epub 2012 Jul 26.

24.

Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR.

Eur Respir J. 2012 Dec;40(6):1555-65. doi: 10.1183/09031936.00046612. Epub 2012 Jun 27. Review.

25.

Usefulness of a mouse model of reversible pulmonary arterial hypertension: be cautious, choose carefully.

Gomez-Arroyo J, Voelkel NF, Bogaard HJ, Taraseviciene-Stewart L.

Am J Respir Crit Care Med. 2012 Jun 15;185(12):1326; author reply 1326-7. No abstract available.

PMID:
22707737
26.

MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD.

Mizuno S, Bogaard HJ, Gomez-Arroyo J, Alhussaini A, Kraskauskas D, Cool CD, Voelkel NF.

Chest. 2012 Sep;142(3):663-672. doi: 10.1378/chest.11-2746.

27.

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Gomez-Arroyo J, Saleem SJ, Mizuno S, Syed AA, Bogaard HJ, Abbate A, Taraseviciene-Stewart L, Sung Y, Kraskauskas D, Farkas D, Conrad DH, Nicolls MR, Voelkel NF.

Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L977-91. doi: 10.1152/ajplung.00362.2011. Epub 2012 Feb 3. Review.

28.

Copper deficiency induced emphysema is associated with focal adhesion kinase inactivation.

Mizuno S, Yasuo M, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Farkas D, Farkas L, Voelkel NF.

PLoS One. 2012;7(1):e30678. doi: 10.1371/journal.pone.0030678. Epub 2012 Jan 20.

29.

Right ventricular systolic dysfunction in patients with reperfused ST-segment elevation acute myocardial infarction.

Van Tassell BW, Bhardwaj HL, Grizzard JD, Kontos MC, Bogaard H, Gomez-Arroyo J, Toldo S, Mezzaroma E, Voelkel NF, Abbate A.

Int J Cardiol. 2012 Mar 8;155(2):314-6. doi: 10.1016/j.ijcard.2011.12.004. Epub 2011 Dec 23. No abstract available.

PMID:
22197216
30.

COPD/emphysema: The vascular story.

Voelkel NF, Gomez-Arroyo J, Mizuno S.

Pulm Circ. 2011 Jul-Sep;1(3):320-6. doi: 10.4103/2045-8932.87295.

31.

The monocrotaline model of pulmonary hypertension in perspective.

Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ.

Am J Physiol Lung Cell Mol Physiol. 2012 Feb 15;302(4):L363-9. doi: 10.1152/ajplung.00212.2011. Epub 2011 Sep 30. Review.

32.

The harmonics of rodent pulmonary hypertension models.

Voelkel NF, Gomez-Arroyo J.

Int J Clin Pract Suppl. 2011 Aug;(172):1-2. doi: 10.1111/j.1742-1241.2011.02712.x. No abstract available.

PMID:
21736674
33.

p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.

Mizuno S, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Voelkel NF, Ishizaki T.

Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L753-61. doi: 10.1152/ajplung.00286.2010. Epub 2011 Feb 18.

34.

Foot deformities associated with Apert syndrome.

Carranza-Bencano A, Gómez-Arroyo JA, Fernández-Torres JJ, Moya Corral F.

J Am Podiatr Med Assoc. 2000 Jun;90(6):322-4. No abstract available.

PMID:
10881466
35.

Xanthomas of the Achilles tendon: report of a bilateral case and review of the literature.

Carranza-Bencano A, Fernádez-Centeno M, Leal-Cerro A, Duque-Jimeno V, Gomez-Arroyo JA, Zurita-Gutierrez M.

Foot Ankle Int. 1999 May;20(5):314-6. Review.

PMID:
10353770
36.

[Acute polymyositis and acute renal failure].

Martín García J, Macías Núñez JF, Tomero JA, Bondia A, Rodríguez Commes JL, Corbacho L, Gómez Arroyo JR, Grande J, Tabernero JM, Flores T.

Rev Clin Esp. 1985 May;176(8):420-2. Spanish. No abstract available.

PMID:
4023326

Supplemental Content

Loading ...
Support Center